Cargando…

Enhancement of electroporation facilitated immunogene therapy via T-reg depletion

Regulatory T cells (T-regs) can negatively impact tumor antigen-specific immune responses after infiltration into tumor tissue. However, depletion of T-regs can facilitate enhanced anti-tumor responses, thus augmenting the potential for immunotherapies. Here we focus on treating a highly aggressive...

Descripción completa

Detalles Bibliográficos
Autores principales: Forde, P F, Sadadcharam, M, Hall, L J, O' Donovan, T R, de Kruijf, M, Byrne, W L, O' Sullivan, G C, Soden, D M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139741/
https://www.ncbi.nlm.nih.gov/pubmed/25034887
http://dx.doi.org/10.1038/cgt.2014.35
_version_ 1782331404383682560
author Forde, P F
Sadadcharam, M
Hall, L J
O' Donovan, T R
de Kruijf, M
Byrne, W L
O' Sullivan, G C
Soden, D M
author_facet Forde, P F
Sadadcharam, M
Hall, L J
O' Donovan, T R
de Kruijf, M
Byrne, W L
O' Sullivan, G C
Soden, D M
author_sort Forde, P F
collection PubMed
description Regulatory T cells (T-regs) can negatively impact tumor antigen-specific immune responses after infiltration into tumor tissue. However, depletion of T-regs can facilitate enhanced anti-tumor responses, thus augmenting the potential for immunotherapies. Here we focus on treating a highly aggressive form of cancer using a murine melanoma model with a poor prognosis. We utilize a combination of T-reg depletion and immunotherapy plasmid DNA delivered into the B16F10 melanoma tumor model via electroporation. Plasmids encoding murine granulocyte macrophage colony-stimulating factor and human B71 were transfected with electroporation into the tumor and transient elimination of T-regs was achieved with CD25-depleting antibodies (PC61). The combinational treatment effectively depleted T-regs compared to the untreated tumor and significantly reduced lung metastases. The combination treatment was not effective in increasing the survival, but only effective in suppression of metastases. These results indicate the potential for combining T-reg depletion with immunotherapy-based gene electrotransfer to decrease systemic metastasis and potentially enhance survival.
format Online
Article
Text
id pubmed-4139741
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-41397412014-08-22 Enhancement of electroporation facilitated immunogene therapy via T-reg depletion Forde, P F Sadadcharam, M Hall, L J O' Donovan, T R de Kruijf, M Byrne, W L O' Sullivan, G C Soden, D M Cancer Gene Ther Original Article Regulatory T cells (T-regs) can negatively impact tumor antigen-specific immune responses after infiltration into tumor tissue. However, depletion of T-regs can facilitate enhanced anti-tumor responses, thus augmenting the potential for immunotherapies. Here we focus on treating a highly aggressive form of cancer using a murine melanoma model with a poor prognosis. We utilize a combination of T-reg depletion and immunotherapy plasmid DNA delivered into the B16F10 melanoma tumor model via electroporation. Plasmids encoding murine granulocyte macrophage colony-stimulating factor and human B71 were transfected with electroporation into the tumor and transient elimination of T-regs was achieved with CD25-depleting antibodies (PC61). The combinational treatment effectively depleted T-regs compared to the untreated tumor and significantly reduced lung metastases. The combination treatment was not effective in increasing the survival, but only effective in suppression of metastases. These results indicate the potential for combining T-reg depletion with immunotherapy-based gene electrotransfer to decrease systemic metastasis and potentially enhance survival. Nature Publishing Group 2014-08 2014-07-18 /pmc/articles/PMC4139741/ /pubmed/25034887 http://dx.doi.org/10.1038/cgt.2014.35 Text en Copyright © 2014 Nature America, Inc. http://creativecommons.org/licenses/by/3.0/ This work is licensed under a Creative Commons Attribution 3.0 Unported License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/
spellingShingle Original Article
Forde, P F
Sadadcharam, M
Hall, L J
O' Donovan, T R
de Kruijf, M
Byrne, W L
O' Sullivan, G C
Soden, D M
Enhancement of electroporation facilitated immunogene therapy via T-reg depletion
title Enhancement of electroporation facilitated immunogene therapy via T-reg depletion
title_full Enhancement of electroporation facilitated immunogene therapy via T-reg depletion
title_fullStr Enhancement of electroporation facilitated immunogene therapy via T-reg depletion
title_full_unstemmed Enhancement of electroporation facilitated immunogene therapy via T-reg depletion
title_short Enhancement of electroporation facilitated immunogene therapy via T-reg depletion
title_sort enhancement of electroporation facilitated immunogene therapy via t-reg depletion
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139741/
https://www.ncbi.nlm.nih.gov/pubmed/25034887
http://dx.doi.org/10.1038/cgt.2014.35
work_keys_str_mv AT fordepf enhancementofelectroporationfacilitatedimmunogenetherapyviatregdepletion
AT sadadcharamm enhancementofelectroporationfacilitatedimmunogenetherapyviatregdepletion
AT halllj enhancementofelectroporationfacilitatedimmunogenetherapyviatregdepletion
AT odonovantr enhancementofelectroporationfacilitatedimmunogenetherapyviatregdepletion
AT dekruijfm enhancementofelectroporationfacilitatedimmunogenetherapyviatregdepletion
AT byrnewl enhancementofelectroporationfacilitatedimmunogenetherapyviatregdepletion
AT osullivangc enhancementofelectroporationfacilitatedimmunogenetherapyviatregdepletion
AT sodendm enhancementofelectroporationfacilitatedimmunogenetherapyviatregdepletion